Effects of Exemestane Therapy on the Lipid Profile of Postmenopausal Women with an Elevated Risk of Developing Invasive Breast Cancer

被引：0
|
作者：
Gatti, M. [1 ]
Venzon, D. [1 ]
Zujewski, J. [1 ]
Korde, L. [1 ]
Isaacs, C. [1 ]
Cohen, P. [1 ]
Warren, R. [1 ]
Gallagher, A. [1 ]
Eng-Wong, J. [1 ]
机构：
[1] Georgetown Univ Hosp, Washington, DC 20007 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P3-11-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-11-01
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Study confirms that raloxifene reduces risk of invasive breast cancer in postmenopausal women
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (05): : 669 - 669
  • [42] Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
    Kjoe, Philippe R. Lee Meeuw
    Kieffer, Jacobien M.
    Small, Brent J.
    Boogerd, Willem
    Schilder, Christina M.
    van der Wall, Elsken
    Kranenbarg, Elma Meershoek-Klein
    van de Velde, Cornelis J. H.
    Schagen, Sanne B.
    JNCI CANCER SPECTRUM, 2023, 7 (02)
  • [43] Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk
    Lippman, Marc E.
    Cummings, Steven R.
    Disch, Damon P.
    Mershon, John L.
    Dowsett, Sherie A.
    Cauley, Jane A.
    Martin, Silvana
    CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5242 - 5247
  • [44] Allostatic load and risk of invasive breast cancer among postmenopausal women in the US
    Wang, Fengge
    Skiba, Meghan B.
    Follis, Shawna
    Liu, Nianjun
    Bidulescu, Aurelian
    Mitra, Anirban K.
    Mouton, Charles P.
    Qi, Lihong
    Luo, Juhua
    PREVENTIVE MEDICINE, 2024, 178
  • [45] Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
    Vogel, Victor G.
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 127 - 137
  • [46] Can exemestane improve adjuvant treatment for postmenopausal women with primary breast cancer?
    Lisa Hutchinson
    Nature Clinical Practice Oncology, 2004, 1 : 24 - 25
  • [47] Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
    T. A. Traina
    I. Poggesi
    M. Robson
    A. Asnis
    B. A. Duncan
    A. Heerdt
    C. Dang
    D. Lake
    M. Moasser
    K. Panageas
    P. Borgen
    L. Norton
    C. Hudis
    M. N. Dickler
    Breast Cancer Research and Treatment, 2008, 111 : 377 - 388
  • [48] Can exemestane improve adjuvant treatment for postmenopausal women with primary breast cancer?
    Hutchinson, Lisa
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (01): : 24 - 25
  • [49] The Effects of Raloxifene and Calcium on Lipid Profile in Postmenopausal Women
    Sapmaz, Kadriye
    Coskun, Ayhan
    Guven, Alanur Menekse
    Kiran, Hakan
    Guven, Melih Atahan
    Kiran, Gurkan
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 4 (04) : 267 - 271
  • [50] A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
    Coombes, RC
    Hall, E
    Gibson, LJ
    Paridaens, R
    Jassem, J
    Delozier, T
    Jones, SE
    Alvarez, I
    Bertelli, G
    Ortmann, O
    Coates, AS
    Bajetta, E
    Dodwell, D
    Coleman, RE
    Fallowfield, LJ
    Mickiewicz, E
    Andersen, J
    Lonning, PE
    Cocconi, G
    Stewart, A
    Stuart, N
    Snowdon, CF
    Carpentieri, M
    Massimini, G
    Bliss, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11): : 1081 - 1092
12345